Introduction
AMR is one of the most important threats to health worldwide (1) . AMR occurs naturally but misuse of antibiotics in human and animals significantly accelerates the process of developing AMR (2) . Antimicrobial agents and drugs are valuable resources that are used every day around the world to treat infections in humans and animals. They save millions of lives in the world each year. However, with the emergence of strains resistant to the antimicrobial agents and drugs, the efficacy of these valuable resources has decreased and public health and economy are threatened (3) . The results of the studies by the European Center for Disease Prevention and Control in 2009 showed that selected multidrug-resistant bacteria were responsible for 25 million deaths and the related costs are estimated at about 1.5 billion Euros in European Union annually (1) . In addition, the yearly cost that AMR imposes on the health system in the United States of America has been estimated to be 21 to 34 billion dollars (4) .
As reported by the WHO, Iran is one of the countries with more than 5 multidrug-resistant bacteria (5) . In addition, as stated by the WHO, AMR is changing into a significant public health issue. Taking into consideration the AMR crisis, a Global Action Plan on Antimicrobial Re-http://mjiri.iums.ac.ir Med J Islam Repub Iran. 2018 (7 Sep); 32:82.
2 sistance (GLASS) was adopted by the World Health Assembly in May 2015 (3) . It listed the 5 following objectives:
1-Promoting effective communication, education, and training to improve awareness and understanding of AMR 2-Promoting surveillance and research to strengthen knowledge and evidence 3-Promoting effective sanitation, hygiene, and infection prevention measures to reduce the incidence of infection 4-Optimizing the use of antimicrobial medicines in human and animal health 5-Developing the economic case for sustainable investment to consider the needs of all countries and increase investment in new medicines, diagnostic tools, vaccines, and other interventions.
The GLASS is aimed to guarantee, for as long as possible, the endurance of effective treatment and prevention of infectious diseases with effective and harmless medicines that are quality-assured, used in a responsible way, and accessible to all who need them. WHO expected that all member countries will develop their own national action plans on AMR in line with the GLASS. Therefore, this project aimed to prepare the first National Action plan of the Islamic Republic of Iran for combating antimicrobial resistance (NAP-IRIAMR). To prepare the NAP-IRIAMR, the literature and strategic plans for the inhibition of resistance designed by pioneer countries were reviewed and the views of the experts and key stakeholders in the field of AMR were obtained.
Methods
The following steps were taken to prepare the NAP-IRIAMR:
1. Conducting a literature review to identify the national action plan, goals, and strategies of other countries to combat AMR 2. In the first stage, key stakeholders were identified through reviewing the literature and available documents and holding a meeting with the team members of the project administration committee that included some experts from the Ministry of Health, Centre for Communicable Diseases (Table 1) .
3. In the second step, representatives of the main stakeholders of the program were invited and the framework proposed by the WHO was presented to them. Then, taking into consideration the goals proposed by the WHO, the literature was reviewed, brain storming sessions were held, and the stakeholders were interviewed. As a result, 5 major areas for combating AMR were identified and 5 objectives were set.
4. In the third step, a series of meetings with all the key stakeholders was held and, using interviews and brain storming sessions, some strategies for each objective, some policies for each strategy, and some measures and indicators for each policy to determine a guide for monitoring and evaluation were determined.
5. In the fourth step, the initial draft of the action plan was sent by email to the main stakeholders to study, review, and approve.
6. In the fifth step, the comments were obtained from the stakeholders and the NAP-IRIAMR was developed. To reach consensus and make a conclusion, the participants' views and comments were analyzed using Delphi method and expert panel.
Results
The key stakeholders who were identified to have a role in combating AMR are listed in Table 1 . Table 2 presents the 5 important fields to slow down the development of AMR and prevent its spread and also the goals associated with these fields.
Discussion
Five main fields were identified to formulate the NAP-IRIAMR. Considering these main fields, 5 objectives were identified. Then, strategies and policies were determined for each of these objectives.
The objectives set for the national action plans for combating AMR in different countries are largely similar to each other. Different countries, including the United States (6), Australia (7), Sweden (8), the United Kingdom (9), Japan (10), Afghanistan (11), Bangladesh (12) and Kenya (13), have similar objectives as follow:
1. Slowing down the emergence of microbial resistance and preventing its spread 2. Strengthening one health surveillance system to combat AMR 3. Encouraging and strengthening research and development for discovering new antimicrobials 4. Training and raising awareness about microbial resistance 5. Strengthening international cooperation to combat 
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AMR
The NAP-IRIAMR similarly includes the abovementioned objectives.
The fight against AMR requires intersectoral cooperation between different sectors, including the sectors working in the fields of health, agriculture, veterinary medicine, education, academic education, and research and development.
Every national action program needs some indicators for monitoring and evaluation of the accomplishment of the set objectives. In view of that, the following indicators were set.
Human-related indices
 Reduce the resistance of S. pneumonia to penicillin to the level set by the National Committee by 2021 Animal-related indices  Reduce resistance of E. coli to tetracycline to the level set by the National Committee or lower  Reduce the resistance of E. coli to third-generation cephalosporin to the level set by the National Committee  Reduce the resistance of E. coli resistant to fluoroquinolones to the level set by the National Committee
Limitations
In spite of inviting all key stakeholders, some stakeholders were absent in the meetings.
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Conclusion
The first National Action Plan of the Islamic Republic of Iran for Combating AMR was prepared to be implemented from 2016 to 2021. This national action plan includes 5 main objectives and 17 strategies. This national action plan is expected to help provide a proper response to AMR and overcome the related problems in Iran.
